We don’t even know how to safely edit human germlines, so we shouldn’t do it
WESLEY W. CHEN June 30 2019 HUMAN GERMLINE GENE EDITING: ENGINEERING AN UNSTOPPABLE TRAIN https://mylaw2.usc.edu/why/students/orgs/ilj/assets/docs/28-2-Chen.pdf
Regardless of the potential impact of gene editing on diversity or inequality, society is not yet equipped with the technology to safely edit human germlines. Since 2003 and the completion of Human Genome Project, we have fully mapped the DNA of human beings.132 However, the knowledge of a human’s nucleotide sequence is a far cry from knowing how genes interact within one another and affect the human physiology. If germline gene modification is likely to have significant medical benefits, is it nevertheless justified if there are still unknown chances that it could have other unintended, adverse consequences as well? Perhaps with some fatal diseases, such as Huntington’s Disease, where a single point mutation causes all symptoms, the benefits of the potential cure may outweigh the safety risks of germline gene editing. In fact, just this year, the U.S. National Academy of Science and the National Academy of Medicine released a report suggesting that such gene editing clinical trials “‘might be permitted, but only following much more research’ on the risks and benefits, and ‘only for compelling reasons and under strict oversight.’” 133 Although clinical germline gene editing may be technologically possible in the near future, the state of current gene editing technology does not yet justify the start of clinical applications. The potential benefits of germline gene editing notwithstanding, society has a responsibility to consider the best interests of the potential human life if gene editing still poses significant adverse risks. Currently, there are still too many issues with off-target gene editing (undesired typos in gene editing) and too many questions regarding what unforeseen consequences gene editing may have on future generations.134 Gene editing technology and our understanding of genetics will develop in time, but until we can definitively engineer an embryo without significant detrimental effects, there will remain significant questions surrounding medical applications of germline gene editing. Therefore, it is imperative that we support basic science research in human embryos if clinical gene editing treatments are ever to see the light of day.